Susquehanna International Group’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $5.21M | Buy |
1,470,925
+602,543
| +69% | +$2.13M | ﹤0.01% | 1175 |
|
|
2024
Q4 | $3.28M | Buy |
868,382
+462,225
| +114% | +$1.75M | ﹤0.01% | 1433 |
|
|
2024
Q3 | $1.32M | Sell |
406,157
-39,881
| -9% | -$129K | ﹤0.01% | 2349 |
|
|
2024
Q2 | $847K | Buy |
446,038
+199,239
| +81% | +$379K | ﹤0.01% | 2775 |
|
|
2024
Q1 | $701K | Sell |
246,799
-316,141
| -56% | -$898K | ﹤0.01% | 3074 |
|
|
2023
Q4 | $8.29M | Buy |
562,940
+346,186
| +160% | +$5.1M | ﹤0.01% | 818 |
|
|
2023
Q3 | $3.97M | Buy |
216,754
+193,751
| +842% | +$3.55M | ﹤0.01% | 1271 |
|
|
2023
Q2 | $496K | Sell |
23,003
-7,607
| -25% | -$164K | ﹤0.01% | 3631 |
|
|
2023
Q1 | $898K | Buy |
+30,610
| New | +$898K | ﹤0.01% | 3047 |
|
|
2022
Q4 | – | Sell |
-10,285
| Closed | -$290K | – | 5793 |
|
|
2022
Q3 | $290K | Sell |
10,285
-127,944
| -93% | -$3.61M | ﹤0.01% | 4269 |
|
|
2022
Q2 | $2.66M | Buy |
138,229
+91,664
| +197% | +$1.77M | ﹤0.01% | 1393 |
|
|
2022
Q1 | $598K | Buy |
+46,565
| New | +$598K | ﹤0.01% | 3487 |
|